Clinical Consultations™: Tailoring Treatment for Cystic Fibrosis Across Life Stages and Evolving Health Needs - CME - Guideline Central

CME

Title
Clinical Consultations™: Tailoring Treatment for Cystic Fibrosis Across Life Stages and Evolving Health Needs
Link
Description
The management of cystic fibrosis (CF) has been radically transformed with the introduction of effective modulators of the protein underlying the pathogenesis of the disease. In addition, newborn screening has improved outcomes through early detection and intervention on gastrointestinal and pulmonary symptoms that can impair development. However, screening can underserve non-White populations due to a variety of biases and biological factors. Moreover, as patient survival continues to improve, there is a greater need for smooth transitions of care through different stages of life. In this program, expert faculty discuss best practices for diagnosis and managing CF in patients, with particular consideration for providing context on the need for screening in non-White populations. They also discuss principles for helping patients with CF transition through different life changes.
Target Audience
This educational activity is directed toward CF specialists, pulmonologists, gastroenterologists, respiratory therapists, dieticians, primary care providers, specialty nurse practitioners, physician assistants, and other HCPs involved in the care of patients with CF.
Learning Objectives
  • Describe strategies to promote early diagnosis in CF
  • Summarize the growing diversity within the adult CF population
  • Implement strategies to enhance patient management for individuals with CF
Estimated Duration
90 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pulmonology, Gastroenterology, Primary Care
Keywords
cystic fibrosis (CF), non-White populations
Disclosures and Disclaimers
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Accredited Providers
  • Physicians’ Education Resource
Commercial Support
  • Vertex Pharmaceuticals
Activity Expiration Date
November 13, 2026
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1.5 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.